What is Codexis Inc (CDXS) stock price today?

Codexis Inc (CDXS) currently trades at $2.82 per share. The stock has a market capitalization of $238.08M and a P/E ratio of —x.

Is CDXS stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Codexis Inc has a Smart Value Score of 46/100 (Grade C), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Codexis Inc's revenue and earnings?

Codexis Inc has trailing twelve-month (TTM) revenue of $70.39M with profit margins of -62.50%. Earnings per share (EPS) is $-0.50.

Is CDXS stock overvalued or undervalued?

Based on our DCF model, Codexis Inc's intrinsic value is $7.06, representing a margin of safety of 83.14%. The stock currently trades at a P/E of —x.

CDXS

Codexis Inc

NASDAQ: CDXS · HEALTHCARE · BIOTECHNOLOGY

$2.82

+0.36% today

Updated 2026-04-30

Market cap

$238.08M

P/E ratio

—

P/S ratio

3.38x

EPS (TTM)

$-0.50

Dividend yield

—

52W range

$1 – $4

Volume

2.6M

Market cap

$238.08M

P/E ratio

—

P/S ratio

3.38x

EPS (TTM)

$-0.50

Dividend yield

—

52W range

$1 – $4

Volume

2.6M

WallStSmart proprietary scores

out of 100

Grade: C

Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

4.0

Profitability

5.7

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$6.58

+133.33%

12-Month target

—

Intrinsic (DCF)

$7.06

Margin of safety

+83.14%

1 Strong Buy4 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $19.57M — positive

+ Revenue growth 81.30% QoQ

+ 83.14% below intrinsic value

Risks

- Thin margins at -62.50%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$138.59M	$70.14M	$59.34M	$70.39M	$70.39M
Net income	$-33.59M	$-76.24M	$-65.28M	$-43.97M	$9.60M
EPS	—	—	—	—	$-0.50
Free cash flow	$2.98M	$-57.06M	$-53.72M	$-23.85M	$19.57M
Profit margin	-24.24%	-108.69%	-109.99%	-62.47%	-62.50%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CDXS	$238.08M	46	5.3	4.0	5.7	5.0	+83.14%	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Codexis Inc trades at $2.82. Our Smart Value Score of 46/100 indicates the stock is fair. TTM revenue stands at $70.39M. with profit margins at -62.50%. Our DCF model estimates intrinsic value at $7.06.

Frequently asked questions

What is Codexis Inc's stock price?

Codexis Inc (CDXS) trades at $2.82.

Is Codexis Inc overvalued?

Smart Value Score 46/100 (Grade C, Sell). DCF value $7.06.

What is the price target of Codexis Inc (CDXS)?

The analyst target price is $6.58, representing +133.3% upside from the current price of $2.82.

What is the intrinsic value of Codexis Inc (CDXS)?

Based on our DCF model, intrinsic value is $7.06, a +83.1% margin of safety versus $2.82.

What is Codexis Inc's revenue?

TTM revenue is $70.39M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio3.38x

ROE-74.90%

Beta2.08

50D MA$1.67

200D MA$2.08

Shares out0.09B

Float0.07B

Short ratio—

Avg volume2.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CDXS vs LLY →CDXS vs JNJ →CDXS vs ABBV →Stock screener →